---
title: "Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294411089.md"
description: "On July 30, 2026, Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a top CNS precision neuroscience biopharmaceutical company, disclosed its plans to release financial results for the second quarter concluding on June 30, 2026. The report, accompanied by a corporate update, is scheduled for Thursday, August 6, 2026, before markets open."
datetime: "2026-07-30T20:07:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294411089.md)
  - [en](https://longbridge.com/en/news/294411089.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294411089.md)
---

# Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

On July 30, 2026, Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a top CNS precision neuroscience biopharmaceutical company, disclosed its plans to release financial results for the second quarter concluding on June 30, 2026. The report, accompanied by a corporate update, is scheduled for Thursday, August 6, 2026, before markets open.

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)

## Related News & Research

- [Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028](https://longbridge.com/en/news/295110125.md)
- [Praxis Precision Medicines grants 7,318 RSUs to 29 new employees under 2024 inducement plan](https://longbridge.com/en/news/294862721.md)
- [Praxis Precision Medicines posts investor deck highlighting late-stage CNS pipeline, upcoming PDUFA dates](https://longbridge.com/en/news/295108601.md)
- [Praxis Precision Q2 net loss widens on higher expenses](https://longbridge.com/en/news/295106132.md)
- [Glenmede Trust Co. NA Sells 2,878 Shares of Praxis Precision Medicines, Inc. $PRAX](https://longbridge.com/en/news/295207096.md)